Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jul-Sep;8(3):67-77.
doi: 10.4103/ajm.AJM_21_18.

Prophylactic mastectomy for the prevention of breast cancer: Review of the literature

Rawan K Alaofi  1 , Mohammed O Nassif  2 , Marwan R Al-Hajeili  3
Affiliations
Review

Prophylactic mastectomy for the prevention of breast cancer: Review of the literature

Rawan K Alaofi et al. Avicenna J Med. 2018 Jul-Sep.

Abstract

The high incidence and recurrence rate of breast cancer has influenced multiple strategies such as early detection with imaging, chemoprevention and surgical interventions that serve as preventive measures for women at high risk. Prophylactic mastectomy is one of the growing strategies of breast cancer risk reduction that is of a special importance for breast cancer gene mutation carriers. Women with personal history of cancerous breast lesions may consider ipsilateral or contralateral mastectomy as well. Existing data showed that mastectomy effectively reduces breast cancer risk. However, careful risk estimation is necessary to wisely select individuals who will benefit from preventing breast cancer.

Keywords: BRCA; breast neoplasms; ductal carcinoma in situ; prophylactic mastectomy; risk reduction.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

References

    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30. - PubMed
    1. SEER Cancer Statistics Review 1975-2014. National Cancer Institute. [Last accessed on 2017 Oct 09]. Available from: https://www.seer.cancer.gov/csr/1975_2014/results_merged/sect_04_breast.pdf .
    1. Basu NN, Barr L, Ross GL, Evans DG. Contralateral risk-reducing mastectomy: Review of risk factors and risk-reducing strategies. Int J Surg Oncol. 2015;2015:901046. - PMC - PubMed
    1. Colleoni M, Sun Z, Price KN, Karlsson P, Forbes JF, Thürlimann B, et al. Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: Results from the international breast cancer study group trials I to V. J Clin Oncol. 2016;34:927–35. - PMC - PubMed
    1. Ghosh K, Hartmann LC. Current status of prophylactic mastectomy. Oncology (Williston Park) 2002;16:1319–25. - PubMed